The Nobel laureate of stem cells will cooperate with China

Martin Evans - who won the Nobel Prize in Physiology and Medicine in 2007, and co-founder of Cell Therapy (CTL) - a high-tech biology company, is working on Research on stem cells and medical applications in Wales, England , has just signed a contract to study stem cell technology to combat the aging process with Zhongyuan Stem Cell Biology Group, China.

Martin Evans

Under the agreement, Zhongyuan Group and CLT will invest about 8 million US dollars to build a new company in Tianjin. The new company is responsible for the research and development achievements of both companies' stem cell research into industrial production.

The prospect of anti-aging research with stem cell technology is enormous.

The British company will provide therapy, treatment with stem cell technology, technologies, products and services related to the most advanced stem cell technology for the new company.

Director of Tianjin Vcanland Group, Zhongyuan's parent company, Li Defu hopes the two companies will make every effort to push China's stem cell industry.